Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06983808

The PREBEAT Trial: Digital PREhaBilitation in thE Cardiac Surgical populATion

The goal of this randomised controlled trial is to learn if a digital prehabilitation program is feasible in patients awaiting cardiac surgery. The main questions it aims to answer are:

1. Is the digital health program usable? 2. Is the digital health program acceptable? 3. Do patients adhere to the digital health program?

Researchers will compare a group using the digital prehabilitation program with standard care to see if the program is feasible and explore any differences in health outcomes.

Participants will

* Use a digital health mobile phone application to guide you through exercise, nutrition and preparation for surgery. * Engage in telehealth consultations. * Complete questionnaires * Complete exercise testing

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Melbourne Health (Royal Melbourne and Melbourne Private Hospital)

Melbourne, Victoria, 3050, Australia

Location status: Recruiting

Location contact

Alistair Royse, MD - Cardiothoracic Surgeon

CONTACT

[email protected]

+61393427000

Alistair Royse, MD - Cardiothoracic Surgeon

PRINCIPAL_INVESTIGATOR

Claire Hines, BSc, BA, M.Physiotherapy

CONTACT

[email protected]

+61404866816

Claire Hines, BSc, BA, M.Physiotherapy

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 21 days+ prior to cardiac surgery
  • Able to provide consent,
  • Proficient in English to understand questionnaires, training instructions and outcome assessments.
  • Digitally literate to independently navigate a smart device and novel application.

Exclusion criteria

  • severe or unstable neurological, cardiorespiratory, or musculoskeletal disease or mental illness that might compromise ability to perform exercise,
  • unstable psychiatric or cognitive disorders,

Treatment and study plan

Digital Cardiac Prehabilitation

Other

Digital Cardiac Prehabilitation - A combined telehealth and app-based preparation for cardiac surgery

Control (Standard treatment)

Other

Standard preparation for surgery as per Melbourne Health hospital procedures and processes. This may include information sessions, pamphlets, and meetings with clinicians. This does not include a prehabilitation program.

Primary outcomes

  1. Usability of Digital Cardiac Prehabilitation as assessed by the Mhealth Application Usability Questionnaire (MAUQ)

    Time frame: 1 day Pre-operatively

    mAUQ is an 18-item questionnaire for patients to evaluate the usability of the digital application under the three domains of; Ease of Use, Interface, Satisfaction and Usefulness.

    Low numbers indicate a higher perception of usability with the digital interface for participants.

  2. Adherence of Digital Cardiac Prehabilitation as measured by usage metrics from Mobile Phone App metrics

    Time frame: 1 day Pre-operatively

    Metrics Used include

    • Time and date: when the application is accessed.
    • Dwell Time: how much time is spent on a particular page.
    • Number of pages viewed: how many views per page per day.
    • User input data: data the user submits in the app, including minutes walked, exercises marked as complete, and questionnaires completed.
  3. Acceptability of Digital Cardiac Prehabilitation as measured by Theoretical Framework of Acceptability Questionnaire (TFA)

    Time frame: 1 day Pre-operatively

    TFA-Q is composed of eight items, in alignment with the eight acceptability constructs (Affective attitude, Burden, Ethicality, Perceived effectiveness, intervention coherence, self-efficacy, opportunity costs, general acceptability).

    High numbers indicate a more acceptable digital experience.

  4. Incidence of Adverse events

    Time frame: Recorded through study completion, an anticipated average of 4 months.

    Adverse events, defined as any undesirable event, such as injury, fall, and discomfort related to prehabilitation will be recorded and severity will be reported according to hospital policy.

    Lower numbers are more favourable, indicating fewer adverse events.

Secondary outcomes

  1. Health service use as measured by Length of Stay (LOS)

    Time frame: 2 weeks post-operatively

    Hospital services use measured by length of stay (LOS) (days) - gained using hospital administrative data.

    Low numbers are preferable, indicating the patient has not stayed as long in hospital.

  2. Health service use as measured by Intensive Care Unit (ICU) Length of Stay (ICU LOS)

    Time frame: 2 weeks post-operatively

    Hospital services use as measured by ICU LOS (days), gained using hospital administrative data.

    Low numbers are preferable, indicating the patient has not required as intensive care.

  3. Mortality as measured by days alive out of hospital (DAoH)

    Time frame: 30 days post-operatively

    Mortality as measured by days alive out of hospital. This data will be gained using hospital administrative records in the event that the patient is uncontactable.

    DAoH should be equal to the number of days since discharge. Where DAoH are lower than the number of days since discharge, this is less favourable, indicating the patient has not survived.

  4. Health service use as measured by Readmissions

    Time frame: 2 weeks, 30 days and 3 months post-operatively

    Hospital services use as measured by the incidence of Readmissions, gained using hospital administrative data.

    Low numbers are preferable, indicating the patient has had less need to return to hospital for care, following discharge.

  5. Health service use as measured by the Health Utilization Questionnaire (HUQ)

    Time frame: Assessed at Baseline, 1 day pre-operatively, then post-operatively at Time Points: 2 weeks, 30 days, and 3 months.

    The HUQ is 12 item survey which assesses the frequency and type of healthcare services accessed by individuals. It gathers data on medical visits, hospital stays, medication use, and other healthcare interactions to evaluate healthcare consumption, and includes modern communication systems of engaging with health care services.

    Low numbers are preferable, indicating less need to engage with health services.

  6. Cost of program delivery as estimated by multiplying the occasions of service by relevant national average hospital award wages for respective staff.

    Time frame: 3 months post-operatively

    Hospital administrative records will be used to supplement resource use data from surveys on consent from participants. In addition, the lead patient-facing researcher will maintain a clinician log, documenting time spent with each patient during the intervention phase to accurately represent the equivalent cost of the intervention. This is expected to include time used for adjusting or maintaining physical activity programs, and any interactions online, via phone, or telehealth. Cost of program delivery will be calculated on conclusion of the PREBEAT trial.

    Low cost is preferable, indicating a potential financial benefit to health services which provide prehabilitation programs.

  7. Recovery as measured by the Post-Operative Quality of Recovery Scale (PostopQRS).

    Time frame: Baseline, 1 day pre-operatively, Post operatively at Time Points: 1 day, 3 days, day of discharge, and 30 days.

    Recovery will be assessed using the 5-domain the Post-Operative Quality of Recovery Scale (PostopQRS). This scale has been designed to quantify quality of recovery ((physiological, emotive, nociceptive, activities of daily living, cognitive and patient perspective) after surgery and anaesthesia. It is comprised of questions that objectively measure patient recovery over multiple time periods. This assessment has been validated and used extensively in the cardiac surgical population. The PostopQRS will be used to monitor multidomain recovery at pre and post intervention timepoints, postoperatively and throughout recovery.

  8. Functional outcome as measured by the Functional Difficulties Questionnaire shortened (FDQs)

    Time frame: Baseline, 1 day pre-operatively, Post operatively at day of discharge, 2 weeks, 30 days, and 3 months.

    The Functional Difficulties Questionnaire shortened (FDQs) is a 10-item functional outcome measure which asks the participant to rate the difficulty they experience when completing a series of 10 upper limb and trunk activities by placing a mark along a 10cm line, with anchors indicating "no difficulty" and "maximum difficulty". For those activities that participants could not attempt whilst completing the questionnaire due to the institution sternal precautions, they are asked to think back to the last time they performed the task.

    Individual scores, measured to the nearest centimetre (cm), are aggregated to form a total out of 130 with higher scores representing greater difficulty experienced during functional activities.

  9. Body metrics as measured by Body Mass Index (BMI)

    Time frame: Baseline, 3 months post-operatively.

    Height (cm) and weight (kg) are taken and placed into the formula: BMI = weight (kg) / [height (m)]². BMI healthy range is 18.5-24.9, with patients being above this overweight (or obese if over 30).

  10. Postoperative pulmonary complications (PPCs) as measured the Melbourne Group Score (MGS)

    Time frame: Post operatively at Time Points: 1 day, 3 days, day of discharge and 30 days

    The Melbourne Group Score (MGS) is a clinical tool used to diagnose postoperative pulmonary complications (PPCs) in patients following surgery. It consists of a set of criteria including abnormal chest x-ray, fever, elevated white cell count, production of purulent sputum, positive respiratory culture, oxygen saturation below 90% on room air, and clinical signs of pulmonary infection.

    If a patient has the presence of four or more criteria in a 24-hour period it is diagnostic of a PPC.

    Lower numbers of PPC through the study are preferable, indicating a lower number of chest infections.

  11. Functional capacity as measured by 1-Minute Sit-to-Stand (1STS)

    Time frame: Baseline, 1 day pre-operatively, Post operatively at day of discharge, 2 weeks, 30 days and 3 months.

    The 1-Minute Sit-to-Stand (1STS) assessment is a simple, quick test used to evaluate lower body strength, endurance, and functional capacity. The participant is asked to stand up from a seated position and sit back down as many times as possible within one minute. The total number of repetitions is recorded as the score.

    Higher scores indicate a better functional capacity.

  12. Inspiratory muscle strength as measured by Maximal Inspiratory Pressure (MIP)

    Time frame: Baseline, 1 day pre-operatively, and post-operatively at discharge.

    Maximal Inspiratory Pressure (MIP) is a measure of inspiratory muscle strength and will be measured via a maximal inspiratory effort using the Powerbreathe KH2. Patients will be asked to sit comfortably in a chair with their feet flat on the ground, with a nose clip on. Patient's will be asked to completely exhale, then form a secure lip seal around the mouthpiece and inhale as forcefully as possible through the device. The KH2 Powerbreathe will measure the pressure generated during this maximal inspiratory effort. This process will be repeated twice, with a 1-minute rest between efforts. The highest pressure generated will be recorded as the patient's MIP.

    Higher pressures are preferable, indicating stronger inspiratory muscles.

  13. Adherence to the Mediterranean diet as measured by The MEDAS (Mediterranean Diet Adherence Screener)

    Time frame: Baseline, 1 day pre-operatively, Post operatively at 2 weeks, 30 days, and 3 months.

    The MEDAS (Mediterranean Diet Adherence Screener) is a 14-item questionnaire designed to evaluate adherence to the Mediterranean diet. Each item assesses the frequency or amount of specific food consumption or dietary habits associated with the Mediterranean diet, such as olive oil, fruits, vegetables, nuts, fish, legumes, and wine. Points are assigned for each item, with higher scores indicating greater adherence to the diet.

  14. Anxiety as measured by The State-Trait Anxiety Inventory (STAI)

    Time frame: Baseline, 1 day pre-operatively, Post operatively at the day of discharge, 2 weeks, 30 days, and 3 months.

    The State-Trait Anxiety Inventory (STAI) is a 40 item psychological assessment tool that measures anxiety in adults and is commonly used in prehabilitation research. It distinguishes between two types of anxiety: state anxiety (a temporary condition experienced in specific situations) and trait anxiety (a general tendency to respond with anxiety across many situations). To reduce the patient assessment burden, the shorted version: State-Trait Anxiety Inventory (STAI-6) will be used in this study.

    Lower scores are preferable, indicating a less anxious patient.

  15. Self-Efficacy as measured by The General Self-Efficacy Scale (GSE)

    Time frame: Baseline, 1 day pre-operatively, Post operatively at the day of discharge, 2 weeks, 30 days, and 3 months.

    The General Self-Efficacy Scale (GSE) is a 10-item questionnaire designed to assess an individual's belief in their ability to handle various stressful situations and challenges. Each item is rated on a 4-point Likert scale, ranging from "Not at all true" to "Exactly true." Higher scores indicate greater self-efficacy.

Study contacts

Contact information is provided by the study sponsor or research team.

Claire Hines, BSc, BA, M. Physiotherapy

CONTACT

[email protected]

+61404866816

Deputy Dean, Engagement Health and Biomedical Sciences, PhD

CONTACT

[email protected]

+61399258444

Sponsors and collaborators

Lead sponsor

Claire Hines

Other

Collaborators

  • Melbourne Health

Registry information

Acronym: PREBEAT

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
May 21, 2025
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.